Advances in the treatment of relapsing–remitting multiple sclerosis – critical appraisal of fingolimod
Claudio Gasperini,1 Serena Ruggieri,2 Chiara Rosa Mancinelli,2 Carlo Pozzilli2 1Department of Neurosciences, S Camillo Forlanini Hospital, Rome, Italy; 2Department of Neurology and Psychiatry, Sapienza – University of Rome, Rome, Italy Abstract: Multiple sclerosis (MS) is a chronic inflamm...
Saved in:
Main Authors: | Gasperini C (Author), Ruggieri S (Author), Mancinelli CR (Author), Pozzilli C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis
by: Ruggieri S, et al.
Published: (2014) -
Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
by: Claudio Gasperini, et al.
Published: (2010) -
Alemtuzumab: evidence for its potential in relapsing–remitting multiple sclerosis
by: Brown JWL, et al.
Published: (2013) -
Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
by: Guarnera C, et al.
Published: (2017) -
CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS
by: Rizaldy Taslim Pinzon, et al.
Published: (2017)